Sonorous Neurovascular Receives FDA IDE Approval for First U.S. Pivotal Trial of a Venous Sinus Stent to Treat Pulsatile Tinnitus

B-SILENT 2 adds a U.S. pivotal study to the company’s international clinical program and advances its cerebral venous disease platform